+6.5%
CLSK vs CME
+63.6%
-57.1%
-79.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -16.3% | +0.4% | -16.7% | -16.1% |
| 7D | -26.5% | -3.3% | -23.2% | -27.3% |
| 30D | -44.1% | +4.0% | -48.1% | -43.1% |
| 3M | -61.2% | +14.1% | -75.3% | -59.4% |
| 6M | -68.2% | +7.1% | -75.3% | -66.4% |
| YTD | -51.7% | +16.5% | -68.1% | -48.7% |
| 1Y | -50.0% | +16.1% | -66.1% | -47.0% |
| 3Y | +6.5% | +64.9% | -58.3% | +11.4% |
| All | +6.5% | +63.6% | -57.1% | +11.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling